Prophylaxis in adult patients with severe hemophilia A or B without inhibitors.

Aledort L, Avila ML, Blanchette V, Lambert T and On behalf of Factor Utilization Expert Working Group of the International Prophylaxis Study Group (IPSG) and other Survey Investigators.